Our Products
Omet Pharma is a generics company. We began selling prescription (Rx) generic medicines in 2022, focused on the Nordic market, initially through tenders, and extending into branded generics.
Rx Prescription generics
Where we concentrate
Omet Pharma concentrates on prescription (Rx) generic medicines for the Nordic market: products that an experienced, small commercial team can bring to market effectively.
A portfolio in prescription generics
The initial focus of Omet Pharma is prescription generic medicine covered by tenders. These products can be commercialised effectively by an experienced, small commercial team, like the Omet Pharma team.
Branded generics
Our scope of focus will extend over the next few years to also include branded generics.
A broad therapeutic range
Rather than concentrating on a single therapeutic niche, our portfolio spans a broad range of therapeutic areas, from everyday primary-care medicines such as pain relief through to specialist treatments and supplements. We assess products opportunistically, wherever our tender and supply-chain model can bring affordable generics to Nordic patients and partners.